Patents by Inventor SKYE MCIVER

SKYE MCIVER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9988633
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: June 5, 2018
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Emery H. Bresnick, Yoon A. Kang, Skye McIver
  • Publication number: 20180010129
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Application
    Filed: August 16, 2017
    Publication date: January 11, 2018
    Inventors: EMERY H. BRESNICK, YOON A. KANG, SKYE MCIVER
  • Patent number: 9771587
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc8, Exosc9, Dis3, Dis3L or Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: September 26, 2017
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Emery H. Bresnick, Yoon A. Kang, Skye McIver
  • Publication number: 20170044543
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc8, Exosc9, Dis3, Dis3L or Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Inventors: EMERY H. BRESNICK, YOON A. KANG, SKYE MCIVER
  • Patent number: 9512430
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc8, Exosc9, Dis3, Dis3L or Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: December 6, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Emery H. Bresnick, Yoon A. Kang, Skye McIver
  • Publication number: 20150011606
    Abstract: Described herein are compositions and methods for enhancing erythropoiesis in an individual in need thereof. Specifically agents that decrease the expression of Exosc8, Exosc9, Dis3, Dis3L or Exosc10, such as inhibitory nucleic acid molecules, produce an increase in red blood cell production in the individual.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 8, 2015
    Inventors: EMERY H. BRESNICK, YOON A. KANG, SKYE MCIVER